000 01398 a2200361 4500
005 20250518035806.0
264 0 _c20200525
008 202005s 0 0 eng d
022 _a1878-5921
024 7 _a10.1016/j.jclinepi.2019.04.020
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMayo-Wilson, Evan
245 0 0 _aHarms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events.
_h[electronic resource]
260 _bJournal of clinical epidemiology
_c09 2019
300 _a11-19 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
650 0 4 _aBipolar Disorder
_xdrug therapy
650 0 4 _aData Accuracy
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aGabapentin
_xadverse effects
650 0 4 _aHumans
650 0 4 _aNeuralgia
_xdrug therapy
650 0 4 _aQuetiapine Fumarate
_xadverse effects
650 0 4 _aRandomized Controlled Trials as Topic
_xstatistics & numerical data
650 0 4 _aResearch Report
700 1 _aFusco, Nicole
700 1 _aLi, Tianjing
700 1 _aHong, Hwanhee
700 1 _aCanner, Joseph K
700 1 _aDickersin, Kay
773 0 _tJournal of clinical epidemiology
_gvol. 113
_gp. 11-19
856 4 0 _uhttps://doi.org/10.1016/j.jclinepi.2019.04.020
_zAvailable from publisher's website
999 _c29657425
_d29657425